Abdalla MMI, Ismail-Khan M. Liver as a metabolic sensor in gestational diabetes: Implications for offspring’s liver and diabetes risk. World J Hepatol 2025; 17(11): 110185 [DOI: 10.4254/wjh.v17.i11.110185]
Corresponding Author of This Article
Mona Mohamed Ibrahim Abdalla, MD, PhD, Department of Human Biology, School of Medicine, International Medical University, No. 126 Jln Jalil Perkasa 19, Bukit Jalil 57000, Kuala Lumpur, Malaysia. monamohamed@imu.edu.my
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Nov 27, 2025 (publication date) through Dec 4, 2025
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Abdalla MMI, Ismail-Khan M. Liver as a metabolic sensor in gestational diabetes: Implications for offspring’s liver and diabetes risk. World J Hepatol 2025; 17(11): 110185 [DOI: 10.4254/wjh.v17.i11.110185]
World J Hepatol. Nov 27, 2025; 17(11): 110185 Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110185
Liver as a metabolic sensor in gestational diabetes: Implications for offspring’s liver and diabetes risk
Mona Mohamed Ibrahim Abdalla, Mohammed Ismail-Khan
Mona Mohamed Ibrahim Abdalla, Department of Human Biology, School of Medicine, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia
Mohammed Ismail-Khan, Department of Gynaecological Oncology, Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead NE9 6SX, United Kingdom
Mohammed Ismail-Khan, Department of Physiology & Medical Education, Shadan Institute of Medical Sciences, Hyderabad 500091, India
Author contributions: Abdalla MMI performed the research, wrote the manuscript and prepared the figures; Ismail-Khan M performed the research and revised the manuscript; and all authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mona Mohamed Ibrahim Abdalla, MD, PhD, Department of Human Biology, School of Medicine, International Medical University, No. 126 Jln Jalil Perkasa 19, Bukit Jalil 57000, Kuala Lumpur, Malaysia. monamohamed@imu.edu.my
Received: June 3, 2025 Revised: July 5, 2025 Accepted: November 7, 2025 Published online: November 27, 2025 Processing time: 180 Days and 23.7 Hours
Abstract
Gestational diabetes mellitus (GDM) is increasingly recognized not only for its immediate obstetric complications but also for its long-term metabolic consequences in both mothers and their offspring. Traditionally, research has emphasized the roles of pancreatic β-cell dysfunction and placental dysregulation in GDM. However, emerging evidence highlights the maternal liver as a central metabolic hub during pregnancy coordinating glucose, lipid, and hormonal adaptations essential for fetal development. This review synthesizes current findings on how GDM disrupts the maternal liver’s adaptive roles, transforming it from a metabolic coordinator into a source of maladaptive endocrine, inflammatory, and nutrient signals. It outlines key mechanistic pathways through which maternal hepatic dysfunction may increase offspring susceptibility to non-alcoholic fatty liver disease and type 2 diabetes mellitus. These include hepatokine dysregulation, altered lipid metabolism, impaired insulin signaling, inflammatory and oxidative stress pathways, and epigenetic and transcriptomic reprogramming. In addition, it explores novel axes such as the gut-liver-placenta interplay, bile acid signaling disruptions, endoplasmic reticulum stress responses, and extracellular vesicle-mediated communication. By reframing the maternal liver’s role in GDM pathophysiology, this review identifies critical windows for early clinical intervention and highlights the potential for liver-focused strategies to prevent the intergenerational transmission of metabolic disease.
Core Tip: Gestational diabetes mellitus does not only affect maternal glucose metabolism, but it can also program lifelong metabolic vulnerabilities in the offspring. This article emphasizes the underappreciated role of the maternal liver as a metabolic sensor that detects pregnancy-related physiological stress and modulates systemic signals accordingly. When impaired by gestational diabetes mellitus, the maternal liver becomes a source of maladaptive endocrine, inflammatory, and metabolic cues that are transmitted to the fetus. These signals can reprogram fetal liver development and increase the risk of non-alcoholic fatty liver disease and type 2 diabetes mellitus in later life. Recognizing the liver’s central role in this process opens new avenues for preventive and therapeutic strategies targeting both maternal and offspring health.